Supplementary Figure S1 from Impact of Biomarker-Matched Therapies on Outcomes in Patients with Sarcoma Enrolled in Early-Phase Clinical Trials (SAMBA 101) Roberto Carmagnani Pestana , Justin T. Moyers , Jason Roszik , Shiraj Sen , David S. Hong , Aung Naing , Cynthia E. Herzog , Siqing Fu , Sarina A. Piha-Paul , Jordi Rodon , Timothy A. Yap , Daniel D. Karp , Apostolia M. Tsimberidou , Shubham Pant , Maria A. Zarzour , Ravin Ratan , Vinod Ravi , Robert S. Benjamin , Alexander J. Lazar , Wei-Lien Wang , Najat Daw , Jonathan B. Gill , Douglas J. Harrison , Valerae O. Lewis , Christina L. Roland , Shreyaskumar R. Patel , J. Andrew Livingston , Neeta Somaiah , Joseph A. Ludwig , Anthony P. Conley , Nelson Hamerschlak , Richard Gorlick , Funda Meric-Bernstam , Vivek Subbiah crossref（2024）
摘要
Treemap of most common drug mechanisms for patients treated in biomarker-matched studies.
更多 查看译文
AI 理解论文
溯源树
样例
